| Literature DB >> 35443710 |
Francesco Zanatta1, Anna Giardini2, Antonia Pierobon3, Marco D'Addario1, Patrizia Steca1.
Abstract
BACKGROUND: The application of virtual reality (VR) and robotic devices in neuromotor rehabilitation has provided promising evidence in terms of efficacy, so far. Usability evaluations of these technologies have been conducted extensively, but no overviews on this topic have been reported yet.Entities:
Keywords: Rehabilitation; Robotics; Systematic Review; Usability; Virtual Reality
Mesh:
Year: 2022 PMID: 35443710 PMCID: PMC9020115 DOI: 10.1186/s12913-022-07821-w
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.908
Eligibility criteria
| • Year of publication timespan: 2000 up to date• Full-text articles published in English in a peer-reviewed journal• Quantitative and qualitative studies• Adult patients undergoing technological neuromotor rehabilitation and/or healthcare professionals• Usability evaluation of the technological devices |
| • Patients undergoing not strictly neuromotor rehabilitation (e.g., cognitive rehabilitation)• Healthy participants or patients suffering from psychiatric disorders• Studies on neuromotor rehabilitation with wearable devices and/or m/eHealth tools exclusively• Conference papers, proceedings, study protocols, commentaries, editorials, position papers, reviews |
Risk of bias and quality assessment criteria
| Research design | Criteria a | Satisfied if |
|---|---|---|
| Qualitative | Credibility | 1.Collection of data over a prolonged period and from a range of participants 2.Use of a variety of methods to gather data 3.Use of a reflective approach through keeping a journal of reflections, biases, or preconceptions and ideas 4.Triangulation used to enhance trustworthiness through multiple sources and perspectives to reduce systematic bias. Main types of triangulation are by: sources (people, resources); methods (interviews, observation, focus groups); researchers (team of researchers versus single researchers); or theories (team bring different perspectives to research question) 5.Member checking |
| Transferability | 1.Can the findings be transferred to other situations? 2.Are the participants and settings described in enough detail to allow for comparisons with your populations of interest? 3.Are there concepts developed that might apply to your clients and their contexts? 4.Were there adequate (thick) descriptions of sample and setting? | |
| Dependability | 1.Is there consistency between the data and the findings? 2.Is there a clear explanation of the process of research including methods of data collection, analysis and interpretation often indicated by evidence of an audit trail or peer review? 3.An audit trail described the decision points made throughout the research process | |
| Confirmability | 1.What strategies were used to limit bias in the research, specifically the neutrality of the data not the researcher? For example, was the researcher reflective and did they keep a reflective journal, peer review such as asking a colleague to audit the decision points throughout the process (peer audit) and checking with expert colleagues about ideas and interpretation of data, checking with participants (participant audit) about ideas and interpretation of data and having a team of researchers | |
| Quantitative | Sample | 1.Sample is representative 2.Selection bias reduced: population based/representative/convenient 3.Size of study in relation to design and question (power) 4.Clearly described participant characteristics |
| Measure | 1.Measure is valid for purpose and reliable 2.Measurement bias is reduced: validity of tools for purpose/reliability of tool/recall/memory | |
| Analysis | 1.Analyses are appropriate to the research question and outcome measure 2.Statistical significance reported 3.Point estimates and variability provided and clinical importance discussed |
a A rating of one (no evidence of study meeting criterion), two (some evidence or unclear reporting) or three (evidence of study meeting criterion) was used to rate each criterion
Fig. 1Flow of studies through the review
Main characteristics of the included studies (n = 68)
| Year of publication | Nation | HDI a (ranking) | Research group specialty field | |||
|---|---|---|---|---|---|---|
| 2016–2021 | 47 (69.1) | USA | 0.926 (17) | 21 (31.0) | Medicine and health sciences | |
| 2011–2015 | 15 (22.0) | Netherlands | 0.944 (8) | 11 (16.2) | Physiatry | 39 (57.4) |
| 2006–2010 | 5 (7.4) | Spain | 0.904 (25) | 11 (16.2) | Neurology | 14 (20.5) |
| 2000–2005 | 1 (1.5) | Italy | 0.982 (29) | 9 (13.2) | Neuroscience | 9 (13.2) |
| Switzerland | 0.955 (2) | 8 (11.8) | Occupational Therapy | 9 (13.2) | ||
| South Korea | 0.916 (23) | 6 (8.8) | Psychology | 4 (5.9) | ||
| Canada | 0.929 (16) | 5 (7.4) | Physiopathology | 3 (4.4) | ||
| Australia | 0.944 (8) | 5 (7.4) | Orthopaedics | 2 (2.9) | ||
| UK | 0.932 (13) | 4 (5.9) | Geriatrics | 2 (29) | ||
| Sweden | 0.945 (7) | 4 (5.9) | Telemedicine | 2 (2.9) | ||
| Saudi Arabia | 0.854 (40) | 3 (4.4) | Public Health | 1 (1.5) | ||
| Taiwan | - | 3 (4.4) | ||||
| Germany | 0.957 (6) | 2 (2.9) | Engineering | |||
| Israel | 0.919 (19) | 2 (2.9) | Biomedical Engineering | 24 (35.3) | ||
| Mexico | 0.779 (74) | 2 (2.9) | Computer Engineering | 11 (16.2) | ||
| Portugal | 0.864 (38) | 1 (1.5) | Mechanical Engineering | 7 (10.3) | ||
| New Zealand | 0.931 (14) | 1 (1.5) | Electrical Engineering | 2 (2.9) | ||
| Austria | 0.922 (18) | 1 (1.5) | ||||
| India | 0.645 (131) | 1 (1.5) | Other sciences | |||
| France | 0.901 (26) | 1 (1.5) | Computer Science | 11 (16.2) | ||
| Japan | 0.919 (19) | 1 (1.5) | Informatics | 4 (5.9) | ||
| Ireland | 0.955 (2) | 1 (1.5) | Physics | 3 (4.4) | ||
| Paraguay | 0.728 (103) | 1 (1.5) | ||||
| Poland | 0.880 (35) | 1 (1.5) | ||||
| Belgium | 0.931 (14) | 1 (1.5) | ||||
| China | 0.761 (85) | 1 (1.5) |
a HDI index is based on 3 dimensions: (a) Life expectance at birth; (b) Expected years of schooling and mean years of schooling; (c) Gross National Income per capita (United Nations Development Programme, http://hdr.undp.org/en. Accessed 1 April 2021)
b Non-cumulative percentages
Main study design characteristics of the included studies (n = 68)
| Study design | Follow-up | Funding(s) | Multicenter | Pilot Study | |||||
|---|---|---|---|---|---|---|---|---|---|
| Feasibility/usability study | 28 (41.2) | Yes b | 8 (11.8) | Yes | 42 (61.7) | Yes | 13 (19.1) | Yes | 25 (36.8) |
| Observational study | 18 (26.5) | No | 60 (88.2) | No | 26 (38.3) | No | 55 (80.9) | No | 43 (63.2) |
| RCT | 9 (13.2) | ||||||||
| Case study | 6 (8.8) | ||||||||
| Clinical trial | 4 (5.9) | ||||||||
| Quasi-experimental study | 3 (4.4) | ||||||||
| Experimental study | 1 (1.5) |
a Non-cumulative percentages b Follow-up range: 1–3 months
Main participants’ characteristics of the included studies (patients, n = 65; healthcare professionals, n = 18)
| Patients | Disease | Healthcare professionals | |||
|---|---|---|---|---|---|
| Inpatients | 19 (29.2) | Stroke | 45 (69.2) | Physiotherapists | 16 (88.9) |
| Outpatients | 21 (32.3) | Musculoskeletal disorders a | 12 (18.5) | Occupational therapists | 4 (22.2) |
| Not defined | 25 (38.5) | Multiple Sclerosis | 6 (9.2) | Physiatrists | 3 (16.7) |
| Traumatic Brain Injury | 6 (9.2) | ||||
| Spinal Cord Injury | 4 (6.1) | ||||
| Parkinson’s disease | 3 (4.6) | ||||
| Other neurological diseases b | 7 (10.8) | ||||
| Geriatric | 1 (1.5) | ||||
| Cardiopulmonary | 1 (1.5) |
a Rheumatoid arthritis, Osteoarthritis, Carpal tunnel syndrome, Hand disability, Chronic pain, Unicompartmental and Total knee arthroplasty b Spinal stenosis, Guillain-barré syndrome, Vestibular disorders c Non-cumulative percentages
Main characteristics of the technological devices and of the interventions of the included studies (n = 68)
| Included studies, | 40 (58.8) | 14 (20.6) | 14 (20.6) |
| VR level of immersion, | |||
| Non-immersive | 28 (70.0) | - | 14 (100.0) a |
| Semi-immersive | 6 (15.0) | - | - |
| Fully-immersive | 6 (15.0) | - | 1 (7.1) a |
| Robot typology, | |||
| Exoskeleton | - | 10 (71.4) | 7 (50.0) |
| End-effector | - | 2 (14.3) | 4 (28.6) |
| Soft-robotics | - | 2 (14.3) | 3 (21.4) |
| Intervention, mean ± SD (range) | |||
| Overall Duration (weeks) | 4.5 ± 2.9 (1–12) | 5.0 ± 2.3 (1–9) | 5.7 ± 1.8 (4–8) |
| n. of sessions | 11.4 ± 18.7 (1–84) | 8.9 ± 7.8 (1–20) | 13.8 ± 14.5 (1–36) |
| Session duration (min) | 33.2 ± 33.7 (3–180) | 55.0 ± 24.8 (10–90) | 40.0 ± 25.0 (10–90) |
a Non-cumulative percentages
Fig. 2Quantitative usability measures of the included studies. SUS, System Usability Scale; VAS, Visual Analogue Scale; NRS, Numerical Rating Scale; SFQ, Short Feedback Questionnaire; TAM, Technology Acceptance Model Questionnaire; USEQ, User Satisfaction Evaluation Questionnaire; SEQ, Suitability Evaluation Questionnaire; QUEST, Quebec User Evaluation of Satisfaction with Assistive Technology 2.0; USE, Usefulness, Satisfaction, Ease of Use Questionnaire; UTA, Users’ Technology Acceptance Questionnaire
Usability and user experience parameters divided for device typology in the included studies (n = 68)
| VR | Robotics | VR and Robotics | n (%a) | ||
|---|---|---|---|---|---|
| Ease-of-use | 33 (82.5) | Ease-of-use | 11 (78.6) | Ease-of-use | 12 (85.7) |
| Learnability | 22 (55.0) | Satisfaction | 8 (57.1) | Learnability | 9 (64.3) |
| Motivation | 18 (45.0) | Effectiveness | 6 (42.9) | Motivation | 5 (35.7) |
| Enjoyment | 13 (32.5) | Learnability | 5 (35.7) | Acceptability | 3 (21.4) |
| Satisfaction | 10 (25.0) | Comfort | 3 (21.4) | Safety | 2 (14.2) |
| Acceptability | 8 (20.0) | Acceptability | 3 (21.4) | Satisfaction | 2 (14.2) |
| Adverse effects | 8 (20.0) | Safety | 2 (14.2) | Engagement | 2 (14.2) |
| Sense of presence | 6 (15.0) | ||||
| Usefulness | 5 (12.5) | ||||
| Engagement | 5 (12.5) |
a Non-cumulative percentages
Fig. 3Overall virtual reality and robotic devices strengths and limitations according to patients’ and healthcare professionals’ perspective